Literature DB >> 20127665

Antiplasmodial and cytotoxic activity of phloroglucinol derivatives from Hypericum erectum Thunb.

Hyung-In Moon1.   

Abstract

The chloroform extracts of whole plants of Hypericum erectum were investigated for antiplasmodial activity against chloroquine-sensitive strains of Plasmodium falciparum. Five phloroglucinol derivatives, otogirin (1), otogirone (2), erectquione A (3), erectquione B (4), and erectquione C (5) were isolated from the whole plants of H. erectum. Also, five compounds were evaluated for in vitro antiplasmodial activities as well as their cytotoxic potential on SK-OV-3 cancer cell line cells. Compounds 2, 4 showed notable growth inhibitory activity against chloroquine-sensitive strains of Plasmodium falciparum with IC(50) values from 5.6 and 7.2 microM. This compound showed no significant cytotoxicity (IC(50) > 150 microM) evaluated using SK-OV-3 cancer cell line cells. (c) 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20127665     DOI: 10.1002/ptr.3104

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  3 in total

1.  The Phytochemistry and Pharmacology of Hypericum.

Authors:  Chuan-Yun Xiao; Qing Mu; Simon Gibbons
Journal:  Prog Chem Org Nat Prod       Date:  2020

2.  Evaluation of Chemical Composition and In-vitro Biological Activities of Three Endemic Hypericum Species from Anatolia (H. thymbrifolium, H. spectabile and H. pseudolaeve).

Authors:  Esra Eroglu Ozkan; Nurten Ozsoy; Tugba Yilmaz Ozden; Gul Ozhan; Afife Mat
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

3.  Evaluation of the cytotoxicity, mutagenicity and antimutagenicity of a natural antidepressant, Hypericum perforatum L. (St. John's wort), on vegetal and animal test systems.

Authors:  Ana Paula Peron; Rosinete Gonçalves Mariucci; Igor Vivian de Almeida; Elisângela Düsman; Mário Sérgio Mantovani; Veronica Elisa Pimenta Vicentini
Journal:  BMC Complement Altern Med       Date:  2013-05-06       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.